Partisan Management Group Inc.
This article was originally published in Start Up
Executive Summary
The strategy of Partisan Management Group Inc. is simple; reliance on a small circle of talented, experienced friends to build fledgling medical device companies. Led by Norman Weldon, PhD, and Karen Cassidy, it works. Partisan, an early-stage venture capital investment group which focuses strictly on seed funding for medical device start-ups, has produced a series of solid gains for its investors, twice scoring what anyone in the industry would consider to be home runs.
You may also be interested in...
Awaiting The Part D Shakeout
The Medicare drug benefit has more plans and fewer enrollees than expected. That is a recipe for consolidation, but will the federal government wait for the market to evolve?
Celltrion Invests $450m Into Incheon Manufacturing Site
Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.
Jefferies' Survey Predicts M&A Rebound In 2021
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: